Study Stopped
Abbott received FDA approval to transition the ongoing Optisure PAS to a Real World Evidence methodology through the EP Passion project
Optisure Lead Post Approval Study
1 other identifier
observational
1,735
7 countries
60
Brief Summary
The purpose of this post approval study is to characterize the chronic performance of the SJM Optisure family of HV leads in patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2014
Longer than P75 for all trials
60 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 7, 2014
CompletedFirst Posted
Study publicly available on registry
September 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedResults Posted
Study results publicly available
July 30, 2025
CompletedJuly 30, 2025
July 1, 2025
5.4 years
September 7, 2014
January 11, 2022
July 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complication Free Survival Rate at 5 Years for Complications Related to the Optisure RV Leads.
Freedom from right ventricle (RV) lead related complications within 30 days of implant at 5 years follow-up Due to early termination of study, the sample size at 5 years follow-up was insufficient to perform the pre-specified primary endpoint analysis. The endpoint was evaluated using the Kaplan-Meier method however the hypothesis test was not performed due to insufficient sample size. The percentage freedom from RV lead related complications was summarized through 5-years from attempted RV lead implant. For subjects who experienced RV lead related complication, the time to event will be calculated from the attempted implant to the date that the first event occurred. For subjects that did not experience the complication, the time to event was censored at their last known event-free time point.
5 years
Study Arms (1)
St. Jude Medical Optisure Lead
Patients implanted with St. Jude Medical Optisure Lead
Interventions
Patients implanted with St. Jude Medical Optisure Lead
Eligibility Criteria
ICD/CRT-D indicated patients
You may qualify if:
- Eligible patients will meet all of the following:
- Have an approved indication, as per ACC/AHA/HRS/ESC guidelines, for implantation of an ICD or CRT-D system for treatment of heart failure or life-threatening ventricular tachyarrhythmia(s).
- Have been implanted with a St. Jude Medical Optisure lead in the last 30 days or are scheduled for an Optisure lead implant.
- Have the ability to provide informed consent for study participation and be willing and able to comply with the prescribed follow-up tests and schedule of evaluations.
- Are 18 years or above, or of legal age to give informed consent specific to state and national law.
You may not qualify if:
- Patients will be excluded if they meet any of the following:
- Enrolled or intend to participate in a clinical drug and/or device study, which could confound the results of this trial as determined by SJM, during the course of this clinical study.
- Have a life expectancy of less than 5 years due to any condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (60)
Baptist Medical Center Princeton
Birmingham, Alabama, 35211, United States
Phoenix Cardiovascular Research Group
Phoenix, Arizona, 85018, United States
St. Bernards (formerly Cardiology Associates of Northeast Arkansas)
Jonesboro, Arkansas, 72401, United States
Raymond Schaerf, MD
Burbank, California, 91505, United States
Desert Heart Rhythm Consultants
Palm Springs, California, 92262, United States
Cardiac Rhythm Specialists, Inc.
Reseda, California, 91335, United States
San Diego Heart Rhythm Center (formerly San Diego Heart and Vascular Associates)
San Diego, California, 92103, United States
Jorge Diaz, M.D. , P.A.
Lake Mary, Florida, 32746, United States
Northside Hospital
Atlanta, Georgia, 30342, United States
Rockford Cardiology Associates
Rockford, Illinois, 61107, United States
Parkview Research Center
Fort Wayne, Indiana, 46845, United States
Iowa Heart Center
West Des Moines, Iowa, 50266, United States
St. Elizabeth Medical Center - South Unit
Edgewood, Kentucky, 41017, United States
Peninsula Cardiology Associates
Salisbury, Maryland, 21804, United States
Mass Heart & Rhythm
Leominster, Massachusetts, 01453, United States
Premier Medical Clinics
Flint, Michigan, 48532, United States
Genesys Regional Medical Center
Grand Blanc, Michigan, 48439, United States
Northern Michigan Hospital
Traverse City, Michigan, 49684, United States
Minneapolis Heart Institute
Minneapolis, Minnesota, 55407, United States
Jackson Heart Clinic
Jackson, Mississippi, 39216, United States
Cardiology Associates of North Mississippi
Tupelo, Mississippi, 38801, United States
HealthCare Partners Cardiology
Las Vegas, Nevada, 89109, United States
Cardiovascular Associates of the Delaware Valley
Haddon Heights, New Jersey, 08035, United States
Lourdes Cardiology Services
Voorhees Township, New Jersey, 08043, United States
Presbyterian Heart Group
Albuquerque, New Mexico, 87106, United States
Maimonides Medical Center
Brooklyn, New York, 11219, United States
Coney Island Hospital
Brooklyn, New York, 11235, United States
Cardiovascular Group of Syracuse
Liverpool, New York, 13088, United States
High Point Regional Health (formerly Carolina Cardiology Cornerstone)
High Point, North Carolina, 27262, United States
CarolinaEast Heart Center
New Bern, North Carolina, 28562, United States
VA Medical Center Cleveland
Cleveland, Ohio, 44106, United States
Great Lakes Medical Research, LLC
Willoughby, Ohio, 44094, United States
Integris Baptist Medical Center
Oklahoma City, Oklahoma, 73112, United States
Providence Heart and Vascular Institute
Portland, Oregon, 97225, United States
Lehigh Valley Hospital
Allentown, Pennsylvania, 18105, United States
Lancaster General Hospital
Lancaster, Pennsylvania, 17602, United States
Arrhythmia Institute
Newtown, Pennsylvania, 18940, United States
The Stern Cardiovascular Foundation
Germantown, Tennessee, 38138, United States
HeartPlace
Bedford, Texas, 76021, United States
VA Medical Center Dallas
Dallas, Texas, 75216, United States
Cardiology Care Consultants
El Paso, Texas, 79936, United States
Scott & White Memorial Hospital
Temple, Texas, 76508, United States
Heart of Dixie Cardiology (formerly Dixie Regional Medical Center - River Road Campus)
St. George, Utah, 84790, United States
Mary Washington Hospital
Fredericksburg, Virginia, 22401, United States
Virginia Cardiovascular Specialists
Richmond, Virginia, 23229, United States
Aurora Medical Group
Milwaukee, Wisconsin, 53215, United States
Ziekenhuis Oost-Limburg
Genk, Limburg, 3600, Belgium
Royal Alexandra Hospital
Edmonton, Alberta, T5H 3V9, Canada
St. Boniface General Hospital
Winnipeg, Manitoba, R2H 2A6, Canada
QE II Health Sciences
Halifax, Nova Scotia, B3H 3A7, Canada
Kingston General Hospital
Kingston, Ontario, K7L 2V7, Canada
London Health Sciences Centre
London, Ontario, N6A 5A5, Canada
Rouge Valley Centenary
Scarborough Village, Ontario, M1B 4Z8, Canada
Institut de Cardiologie de Montreal (Montreal Heart Inst.)
Montreal, Quebec, H1T1C8, Canada
Universitäts-Herzzentrum Freiburg - Bad Krozingen
Bad Krozingen, 79189, Germany
Tokyo Women's Medical University
Shinjuku-Ku, Kanto, 162-8666, Japan
Osaka City University Hospital
Abeno-ku, Osaka, 545-8565, Japan
Jichi Medical University Hospital
Shimotsuke-shi, Tochigi, 329-0498, Japan
Mc-Tronik
Lodz, Poland
Santa Maria Hospital
Lisbon, Lisbon District, 1649-035, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nicole Harbert, Program Director
- Organization
- Abbott
Study Officials
- STUDY DIRECTOR
Nicole Harbert
Abbott
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 7, 2014
First Posted
September 10, 2014
Study Start
August 1, 2014
Primary Completion
December 16, 2019
Study Completion
June 30, 2020
Last Updated
July 30, 2025
Results First Posted
July 30, 2025
Record last verified: 2025-07